You are using an outdated browser. Please upgrade your browser to improve your experience.
Washington Manual of Oncology

"Try before you buy" - Download the FREE App, which includes sample content

"Try before you buy" - Download the FREE App, which includes sample content

Washington Manual of Oncology

by Skyscape Medpresso Inc
Washington Manual of Oncology
Washington Manual of Oncology
Washington Manual of Oncology

What is it about?

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase is required to unlock all content.

Washington Manual of Oncology

App Details

Version
5.0.10
Rating
NA
Size
50Mb
Genre
Medical Education
Last updated
November 5, 2022
Release date
June 15, 2017
More info

App Screenshots

Washington Manual of Oncology screenshot-0
Washington Manual of Oncology screenshot-1
Washington Manual of Oncology screenshot-2
Washington Manual of Oncology screenshot-3
Washington Manual of Oncology screenshot-4
Washington Manual of Oncology screenshot-5
Washington Manual of Oncology screenshot-6
Washington Manual of Oncology screenshot-7

App Store Description

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase is required to unlock all content.

Focusing on the essential information you need to know for the clinical practice of oncology, this practical volume in the Lippincott Manual series provides concise, high-yield content that reflects today’s fast-changing advances in the field. In one convenient, portable resource, you’ll find complete coverage of cancer management, all at your fingertips for quick review and reference. The Washington Manual® of Oncology,  by Drs. Daniel Morgensztern, Armin Ghobadi, and Ramaswamy Govindan, is an ideal reference for oncologists, residents, fellows, medical students, nurse practitioners, and physician assistants.

The latest, most reliable cancer management recommendations in the famous fast-access Washington Manual® outline format that includes easy-to-follow guidelines, tables, graphs, and algorithms.

Thoroughly revised from cover to cover, including new content on gene and cellular immunotherapy for cancer, management of antineoplastic-induced nausea and vomiting as well as new sections on neuroendocrine carcinoma and myelodysplastic syndromes.
Concise, clearly written sections on the principles of oncology, site-specific cancers, and therapy and support.

Key information on chemotherapeutic agents and regimens in the appendices

* No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms.

ISBN 10: 1451193475
ISBN 13: 9781451193473

SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.

Yearly auto-renewing payments- $49.99

Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Author(s): Ramaswamy Govindan, MD; Daniel Morgensztern, MD
Publisher: Wolters Kluwer Health | Lippincott Williams & Wilkins

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.